INTRODUCTION
Spermatogenesis is a consecutive cellular differentiation process. In the fetal mouse testis, gonocytes undergo self-renewal and proliferation until embryonic day 13.5 and then enter mitotic arrest. 1 At postnatal day (PN) 1-2, gonocytes reenter the mitotic cycle and migrate to the periphery of the testicular cords; at PN 3-5, they give rise to spermatogonial stem cells (SSCs). [2] [3] [4] SSCs are present as single cells (A s ) that proliferate to renew the stem cell pool and produce undifferentiated spermatogonia (A pr and A al ). 5 A al spermatogonia then differentiate into A 1 spermatogonia, which undergo five rounds of cell division to form differentiated B spermatogonia that differentiate into preleptotene spermatocytes. 6 Preleptotene spermatocytes undergo one round of DNA duplication and two rounds of meiosis to form haploid spermatids, which then undergo a complicated metamorphosis involving nuclear structural modifications, acrosome formation, and flagellum establishment to become morphologically complete spermatozoa. [7] [8] [9] ORIGINAL ARTICLE
The role of tyrosine phosphatase Shp2 in spermatogonial differentiation and spermatocyte meiosis
In spermatogonia, a number of cytoplasmic signaling proteins, including phosphoinositide-3 kinase (Pi3k), protein kinase B (Akt/PKB), rat sarcoma viral oncogene (Ras), mitogen-activated protein kinase (Mapk), and mammalian target of rapamycin (mTOR), orchestrate these signals to maintain the spermatogonial proliferation/ differentiation balance and proper differentiation. 12, 13 In male mice, RA signaling induces the production of proteins through Stra8 and Kit, which activates germ cell differentiation and initiates meiosis. 14 In addition to the classical nuclear receptor signaling pathway, RA also activates Pi3k/Akt or Ras/extracellular-regulated protein kinase (Erk) signaling cascades to stimulate the expression of meiotic genes, such as disrupted meiotic cDNA 1 (Dmc1), REC8 meiotic recombination protein (Rec8), and synaptonemal complex protein 3 (Sycp3), 15 which form a series of meiotic structures that are responsible for the drastic morphologic changes of chromosomes during meiosis. 16 Src homology domain tyrosine phosphatase 2 (Shp2), a nonreceptor tyrosine phosphatase encoded by the protein tyrosine phosphatase, nonreceptor type 11 (Ptpn11) gene, plays an important role in organ development by regulating multiple intracellular signaling pathways, notably the Ras/Erk Mapk, Janus kinase/signal transducer and activator of transcription 3 (Jak/Stat3), and Pi3k/Akt cascades. [17] [18] [19] [20] Shp2 is expressed in testicular somatic cells and germ cells. 21 Our previous work demonstrated that conditional knockout of Shp2 in Sertoli cells in mice leads to an upregulation of Scf signaling, resulting in premature differentiation of SSCs. 22 Puri et al. 23 showed that Shp2 deletion in gonocytes (prospermatogonia) in mice, using DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 (Vasa)-cre, severely impaired the transition of gonocytes into SSCs and led to the loss of undifferentiated spermatogonia in postnatal testes. However, the effect of Shp2 on later spermatogonial functions was not revealed. We and other researchers have also observed that Shp2 protein levels are high in spermatogonia but drop to low levels in spermatocytes and spermatids, 21 suggesting that Shp2 has a specific role in the differentiation of spermatogonia and the initiation of spermatocyte meiosis.
To elucidate the role of Shp2 in the transition from spermatogonia to spermatocytes, we deleted Shp2 in postnatal germ cells in mice using the Stra8-cre model and found that spermatogenesis was disturbed. The proliferation/differentiation balance in mutant spermatogonia was disrupted, and differentiation was accelerated. Shp2 deletion in spermatocytes also suppressed the expression of functional meiotic genes, which disturbed meiosis and ultimately led to spermatocyte loss.
MATERIALS AND METHODS

Transgenic mouse breeding and reproductive ability test
Mice were housed under standard conditions and had free access to food and water. All experimental procedures were performed according to the approved guidelines from the Animal Welfare Committee of Research Organization (X200811) of Xiamen University (Xiamen, China). All animal experiments conducted as part of this study were approved by the Animal Ethics Committee of Xiamen University. To generate the postnatal germ cell-specific Shp2 conditional knockout mice, Shp2 f/f mice were bred with Stra8-cre mice. To increase the efficiency of Shp2 deletion, Stra8-cre-Shp2 f/null F2 mice were generated and used as germ cell-specific Shp2 knockout (GCKO) mice, and Shp2 f/null mice served as control mice. The genotype of offspring was confirmed by PCR using gene-specific primers ( Supplementary Table 1 ).
To assay reproductive ability, adult 8-week-old GCKO, Shp2 f/null and Shp2 f/f male mice from the same litter were grouped and mated with wild-type female mice. On the second day, female mice with vaginal plugs were moved into another cage and observed until the pups were born. One week later, male mice were again mated with other wild-type female mice. The mating experiment was successively repeated ten times for each male mouse. The number of litters and pups was statistically analyzed.
Isolation and purification of primary germ cells
Germ cell mixtures were isolated by a two-step enzymatic digestion as described previously. 24 Germ cells from the testes of 7-day-old (for the isolation of spermatogonia) and 17-day-old control males (for the isolation of preleptotene and leptotene/zygotene spermatocytes) were isolated by gravity sedimentation with a STA-PUT device (56700-012, ProScience, Toronto, Canada) and characterized from cytological classification and morphology analysis as described previously. 25 The purity of each germ cell population was confirmed by the expression of marker genes and morphology (Supplementary Figure 1) . In general, more than 90% purity was achieved.
Quantitative real-time polymerase chain reaction (qRT-PCR)
Total mRNA was isolated from testes or separated germ cells by TRIzol reagent (Invitrogen, Waltham, MA, USA). cDNAs were produced with an PrimeScript™ II 1 st Strand cDNA Synthesis Kit (TAKARA, Tokyo, Japan) following the standard manufacturer's instructions. qRT-PCR was performed in an ABI 7500 PCR system (Applied Biosystems, Foster City, CA, USA). Primer information is presented in Supplementary Table 1 , and mRNA expression levels were normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) levels to determine the relative expression levels of genes.
anti-Shp2 (1:200, Santa Cruz Biotechnology), anti-Plzf (1:500, Santa Cruz Biotechnology), anti-cleaved caspase 3 (1:200, Cell Signaling Technology, Boston, MA, USA), anti-Dmc1 (1:200, Abcam), anti-Smc3 (1:500, Abcam), and anti-DNA repair recombinase rad51 (Rad51; 1:200, Invitrogen). After being washed three times with PBST, the samples were incubated with the following secondary antibodies at a 1:200 dilution for 1 h at 37°C: Alexa Fluor 594/488-labeled antirabbit or anti-mouse IgG (YEASEN, Shanghai, China). The slides were subsequently washed three times in PBST and mounted with Vectashield containing 4'-6-diamidino-2-phenylindole (DAPI; Vector Laboratories, Burlingame, CA, USA).
TdT-mediated dUTP Nick-End Labeling (TUNEL) assay
Tissue sections were prepared as described above and were treated with 0.1% (v/v) Triton X-100 in 0.1% (w/v) sodium citrate solution for 10 min at 37°C and stained with the in situ Cell Death Detection Kit (Roche Applied Science, Basel, Switzerland) according to the manufacturer's protocol. Finally, the sections were incubated with Vectashield containing DAPI.
GC-1 cell line culture and treatment
Mouse-derived GC-1 cells (a gift from Dr. Fei Sun, Nantong University, Nantong, China) were cultured in Dulbecco's Modified Eagle Medium (DMEM; Gibco, Grand Island, CA, USA) supplemented with 10% (v/v) fetal bovine serum (FBS; Gibco). To knock down Shp2, the cells were infected with a high titer of lentivirus expressing Shp2 shRNA for 48 h, as described previously. 27 For retinoic acid (RA; Sigma-Aldrich, Saint Louis, MO, USA) treatment, the cells were incubated for the indicated times in medium containing 0.2% FBS and 3 µmol l −1 RA which is dissolved in dimethyl sulfoxide (DMSO).
Western blot
Western blot was performed as previously described. 22 In brief, separated proteins on nylon membranes were incubated with specific primary antibodies such as anti-Shp2 (1:1000) and anti-tubulin (1:1000, Proteintech, Wuhan, China) at 4°C overnight and then with secondary antibodies (ZSbio) at 37°C for 2 h. The results were visualized with enhanced chemiluminescence. Grayscale bands were quantified using Quantity One software (Bio-Rad, Hercules, CA, USA).
Statistical analysis
Statistical analysis was performed using GraphPad prism version 6.0 (GraphPad Software Inc., La Jolla, CA, USA). Data were presented as mean ± standard deviation (s.d.) and were analyzed by Student's t-test. P < 0.05 was considered statistically significant. Figure 2) .
RESULTS
Deletion of Shp2 and its effect on spermatogenesis and fertility In mouse testicular tissue or purified cells, Shp2 protein was abundant in spermatogonia and Sertoli cells but decreased to low levels in meiotic cells such as spermatocytes and spermatids (Supplementary
To define the role of Shp2 in the early stages of spermatogenesis, we employed Stra8-cre to delete the Shp2 gene in male germ cells. Stra8-cre activity is restricted to the postnatal male germline, where it is detectable in undifferentiated spermatogonia in a few days after birth. 28 Here, we produced a Stra8-cre-Shp2 f/null F2 generation as GCKO mice and used Shp2 f/null mice as the control. Immunofluorescence analysis revealed that Shp2 was efficiently and specifically deleted in postnatal spermatogenic cells in juvenile GCKO mice (3-week-old) (Figure 1a , green), although Shp2 ablation efficiency decreased with age ( Supplementary Figure 3, red) .
Although the mutant mice had a normal body weight, their testes were smaller than those of control mice at various ages (Figure 1b and 1c) . Histological changes in testis tissue were observed with H and E staining. In 2-3-week-old juvenile control mice, the germ cells showed a regular arrangement, and spermatogenic development was clearly observed in the seminiferous tubules (Figure 1d , top panels). However, in GCKO mice of the same age, spermatogenic development was impaired, and germ cells were markedly decreased in number and disorderly arranged in most of seminiferous tubules in the testes from GCKO mice in particular, spermatids were nearly undetectable (Figure 1d , bottom panels). The defective spermatogenetic phenotype was also observed in many seminiferous tubules in the testes from 4-to 8-week-old GCKO mice. However, spermatogenesis in some seminiferous tubules recovered in older mice (Supplementary Figure 4a) .
Adult GCKO and age-matched control male mice (Shp2 f/null ) were mated with wild-type females beginning at 8-week-old to perform a successive breeding assay (see details in the Methods section). In a total of 96 matings, the GCKO male mice (n = 8) sired a total of 310 pups (68 litters), while control mice (n = 7) sired a total of 461 pups from 67 litters. The average number of pups per litter from GCKO mice was lower than that from control mice (P < 0.01; Supplementary Table 2 ). In addition, the number of spermatids was dramatically decreased in adult GCKO mice, as visualized by Acvr1 (a spermatid marker protein; Supplementary Figure 4b ) and DNA content analysis with flow cytometry (Supplementary Figure 4c and 4d) . Approximately half (48%) of all pups from Stra8-cre-Shp2 f/null (GCKO) male mice were Shp2 positive (F/+) rather than the theoretically expected Shp2 heterozygous (null/+) genotype (Supplementary Table 3 ).
The effect of Shp2 deletion on spermatogonial differentiation
To understand the spermatogenetic defect due to Shp2 ablation, we first discovered the effect of Shp2 deletion on the balance between undifferentiated spermatogonia proliferation and differentiation. Plzf is an undifferentiated spermatogonia marker protein, 29 and the number of Plzf-positive spermatogonia was reduced in 7-dayold GCKO mice by both immunostaining and qRT-PCR analyses (Figure 2a, 2b and Supplementary Figure 5 ). Loss of Shp2 also suppressed the expression of Etv5 and Bcl6B (Figure 2b , qRT-PCR), two genes activated by Gdnf and Fgf signalings that play key roles in maintaining the balance between spermatogonia self-renewal and proliferation. In addition, the number of phosphorylated histone H3 (PH3; a cell proliferation marker 30 ) positive undifferentiated spermatogonia (PH3 + , Plzf + ) was also reduced in the testes from GCKO mice (Figure 2c and Supplementary Figure 5 ). c-Kit is a marker of differentiating spermatogonia, and c-Kit gene transcription in postnatal germ cells is concordant with the first appearance of differentiating spermatogonia, which occurs at approximately PN7 in mice. 31 Here, although c-Kit was expressed at low levels in a few spermatogonia from control mice, it was highly expressed in many spermatogonia in GCKO mice (Figure 2d and Supplementary Figure 5 ) at PN7. The mRNA levels of c-Kit and deleted in azoospermia like (Dazl) were also upregulated in Shp2depleted testes from 7-day-old GCKO mice, while SRY-box 3 (Sox3) transcription was not affected (Figure 2e) .
The effect of Shp2 deletion on spermatocyte meiosis and death
We observed spermatocyte meiosis by immunofluorescence staining with Sycp1 and Sycp3, which are components of the germ cell-specific synaptonemal complex (SC). 32 In control mice, Sycp3 expression was low in preleptotene spermatocytes located in the basal compartment of seminiferous tubules at PN8 to PN10 and became strong and thread-like in leptotene and zygotene spermatocytes, which clustered into the adluminal compartment of seminiferous tubules at PN11 to PN13 (Figure 3a , top panels). Sycp1 expression was first noted in zygotene spermatocytes and was high in pachytene spermatocytes. Here, Sycp1 was coexpressed with Sycp3 at PN14 in spermatocytes (Figure 3a In addition, although not all the tubules were completely affected as described above, the number of meiotic cells was dramatically decreased in GCKO mice compared with that in control mice (Figure 3b) . In GCKO mice, cell apoptosis occurred at PN9 and increased notably starting at PN10 (Figure 4a and 4b) . These apoptotic cells were scattered in the adluminal compartment of seminiferous tubules (Figure 4a, bottom panel) . Moreover, cleaved caspase 3 levels were markedly increased in GCKO mice from PN10, which confirmed the observation of spermatocyte death induced by Shp2 deficiency (Supplementary Figure 6) . 
The expression of meiotic genes and meiotic structure formation in Shp2-ablated spermatogenic cells
To explore the mechanism underlying the meiosis defection, meiotic genes' expressions in spermatogonia (SG), preleptotene spermatocytes (PlpSC), and leptotene/zygotene spermatocytes (L/ZSC) from control and GCKO mice were measured by qRT-PCR. The expressions of several genes involved in meiotic recombination, such as initiator of meiotic double-stranded breaks (Spo11), PR domain containing 9 (Prdm9), Dmc1, Rad51, and mutS homolog 4 (Msh4), and of genes involved in meiotic synapses, such as Sycp1, Sycp3, synaptonemal complex central element protein 2 (Syce2), structural maintenance of chromosomes 3 (Smc3), and stromal antigen 1 (Stag1), were attenuated in preleptotene spermatocytes from GCKO mice compared to those from control mice (Figure 5a) .
We evaluated the impact of meiotic protein deficiency by performing nuclear spreading assays with immunofluorescence staining of several marker proteins. Dmc1 forms early recombination nodules (ENs) with Rad51 to repair meiotic double-strand breaks (DSBs) by homologous recombination. 33, 34 In control spermatocytes, Rad51/Dmc1 formed ENs along the axial elements (AEs), starting from the leptotene stage, and the number of these complexes gradually decreased with maturation (Figure 5b) . However, in GCKO spermatocytes, Rad51 expression appeared to be normal at the leptotene stage but completely absent at the zygotene stage, and Dmc1 was undetectable at any of these stages (Figure 5b) . Smc3, a cohesion protein that forms the central element of the synaptonemal complex (SC) with other proteins, 35 was localized along the entire SC in control leptotene and zygotene spermatocytes, but was completely absent when Shp2 was deleted (Figure 5b) .
Knockdown of Shp2 and its effect on RA signaling and target gene expression
RA is an important signal for initiating meiosis and inducing meiotic gene expression. 36, 37 In addition to the classical nuclear receptor signaling pathway, RA also activates the Pi3k/Akt or Ras/Erk signaling cascade to stimulate meiotic gene expression. 15 As a crucial regulator of the Pi3k/Akt and Ras/Erk pathways, Shp2 might also regulate RA signaling through these cytoplasmic signaling pathways. To assess this hypothesis, Shp2 was specifically knocked down in GC-1 cells, a germ cell line that corresponds to a stage between B type spermatogonia and primary spermatocytes, 38 with lentivirus containing plasmid expressing short hairpin RNA targeting Shp2 (sh-Shp2) or control (shN). Shp2 protein levels were obviously decreased (by more than 60%) in GC-1 cells infected with sh-Shp2 lentivirus (Figure 6a) . Then, we checked the expressions of meiotic genes (Sycp3 and Dmc1) after 48 h of RA treatment by qRT-PCR and found that Shp2 knockdown downregulated RA-stimulated meiotic gene expression in GC-1 cells (Figure 6b) . Furthermore, the cells were stimulated with 3 µmol l −1 RA for 15 min, and Akt and Erk phosphorylation was checked by Western blot with specific antibodies. The results showed that RA increased Akt and Erk signaling in GC cells, while Shp2 ablation impaired this effect, reducing the RA-induced phosphorylation of Akt and Erk (Figure 6c and 6d) .
DISCUSSION
By the use of conditional knockout mice, the present study demonstrated that loss of Shp2 in postnatal germ cells leads to uncontrolled spermatogonial differentiation and defective spermatocyte meiosis, revealing a critical role of Shp2 in spermatogenesis.
Shp2 deletion in germ cells seriously impaired spermatogenesis in our animal model. Histological observations revealed that germ cells were markedly decreased in number and disorderly arranged in most seminiferous tubules in the testes from 2-3-week-old GCKO mice, and spermatids were nearly undetectable. Immunofluorescence staining also revealed that the spermatocyte population was sharply decreased, and cell apoptosis increased from PN10. Few pachytene spermatocytes were observed at PN11-13. These findings demonstrate that Shp2 is crucial for spermatogenesis and that germ cells lacking Shp2 are not able to develop into spermatids. In the breeding test of Stra8-cre-Shp2 f/null (GCKO) male mice and wild-type female mice, approximately 50% of the pups were Shp2 heterozygous (F/+), rather than the expected 100% Shp2 +/null pups, which suggests that no spermatozoa were derived from Shp2 null/null germ cells.
However, any incomplete Shp2 deletion with the Stra8-cre system would dilute the defect in spermatogenesis and weakened the GCKO mouse phenotype. Although Stra8-cre is a powerful tool for studying spermatogenesis that has been employed by several groups, it is well known that incomplete deletion in the Stra8-cre model disturbs the phenotype and brings much confusion for researchers. 39, 40 The Stra8-cre deletion efficiency may be higher in undifferentiated spermatogonia 41 In our model, Shp2 was efficiently and specifically deleted in postnatal spermatogenic cells in younger GCKO mice, but the Shp2 ablation efficiency decreased with age. Therefore, the spermatogenic defect phenotype was clear in the first cycle of spermatogenesis (at 3-week-old), but was weaker in the second and later spermatogenic waves.
Shp2 protein was abundant in spermatogonia, but its level sharply decreased in meiotic spermatocytes, indicating that Shp2 has various roles in spermatogenesis. Using Vasa-cre, our group 22 and Puri et al. 23 deleted the Shp2 gene in mouse gonocytes (prospermatogonia) and demonstrated that Shp2 is an essential protein for the survival and self-renewal of SSCs. However, the role of Shp2 in later spermatogonia development was not revealed because the population of undifferentiated spermatogonia gradually decreased and completely disappeared by 3-week-old in Vasa-cre-induced Shp2 knockout mice. Here, our experiments using the Stra8-cre mouse model complemented the research on Shp2 in early spermatogenesis and showed that Shp2 deletion in undifferentiated spermatogonia reduced proliferation and accelerated differentiation, indicating that Shp2 also plays a positive role in maintaining the balance between spermatogonial proliferation and differentiation and that its proper withdrawal is beneficial to spermatogonial differentiation.
Shp2 also plays important physiological roles in the development of several other organs, such as the heart, pancreas, liver, and mammary gland, as a signaling protein that regulates the balance between proliferation and differentiation in progenitor stem cells. [42] [43] [44] In these tissues, Shp2 plays dual roles in regulating several signaling factors, such as Fgf, Gdnf, Egf, and Scf, which balance proliferation and differentiation. [45] [46] [47] As a typical protein tyrosine phosphatase (PTP), Shp2 dephosphorylates receptor tyrosine kinases (RTKs) and suppresses these signals. On the other hand, Shp2 can also enhance these signals to activate the downstream cytoplasmic signaling proteins Erk and Akt by dephosphorylating these proteins' activators (such as Src family kinases) or inhibitors (such as Sprouty, RasGAP). 18 In spermatogenesis, these RTK signals balance spermatogonia proliferation and differentiation. 7, 10 Therefore, in spermatogonia, Shp2 may act as a gatekeeper to govern the balance between self-renewal and differentiation by orchestrating multiple signaling pathways, and its withdrawal induces unlimited spermatogonial differentiation.
In normal mouse spermatogenesis, undifferentiated spermatogonia differentiate into preleptotene spermatocytes at approximately PN8. 48 These spermatocytes reach the leptotene stage at approximately PN10 and the pachytene stage at PN14-16 in the mouse, depending on the strain. 2, [49] [50] [51] In our transgenic mice, spermatocyte meiosis was initiated at PN11 and reached the pachytene stage at PN14 in control mice. However, in GCKO mice, leptotene and zygotene spermatocytes appeared at PN9, and pachytene-like spermatocytes emerged precociously at PN11, which indicated that meiosis was shifted earlier and shortened. Moreover, the spermatocyte population in GCKO mice was markedly decreased, and apoptosis appeared at PN9, suggesting that the disrupted meiosis in Shp2-deficient spermatocytes leads to cell death. Furthermore, we found that the expressions of many meiotic genes in preleptotene spermatocytes were attenuated, which may be a main reason for the defects because meiosis depends on meiotic genes to form a series of structures that are responsible for the drastic morphological changes in chromosomes. 16 As evidence, the Rad51 and Dmc1 deficiency in Shp2-deleted spermatocytes led to the failed formation of early recombinant nodules in meiosis and a decrease in Smc3 disrupted SC formation.
The attenuation of meiotic gene expression may be due to disturbed meiotic progression. Spermatocytes require a long preleptotene stage to accumulate sufficient resources, especially functional meiotic proteins, for meiosis. A short or untimely preleptotene stage in spermatocytes may interrupt the transcription of meiotic genes. In addition, the loss of Shp2 may impair the expression of meiotic genes. RA is a meiotic initiation signal that activates Stra8 and Dazl to induce the expression of meiotic genes, such as Dmc1, Rec8, and Sycp3. 15 Using GC-1 cells, a germ cell line with a stage between B type spermatogonia and primary spermatocytes, 38 we found that Shp2 knockdown inhibited the RAinduced phosphorylation of Akt and Erk and the expression of meiotic genes Sycp3 and Dmc1. Thus, Shp2 may also mediate the expression of meiotic genes by regulating RA signaling in spermatocytes.
Shp2 plays pleiotropic roles in human physiological processes and its dysfunction is involved in multiple of human developmental disorders and diseases. 17, 18 Therefore, Shp2 is regarded as a potential therapeutic target. Gain-of-function mutations of the Ptpn11 gene have been associated with Noonan syndrome and several cancers, including leukemia, lung, and breast cancer. [52] [53] [54] Allosteric inhibition of Shp2 has been demonstrated to be an effective therapeutic approach for cancer. 55 Lots of inhibitors of Shp2 activity have been identified as candidate drugs for cancer. 56, 57 On the other hand, loss-of-function mutations of the Ptpn11 gene have been previously identified, and these mutations result in several human developmental pathologies, such as LEOPARD syndrome, metachondromatosis, and hypertrophic cardiomyopathy. [58] [59] [60] Thus, activation of Shp2 is also thought to be a potential therapeutic approach for the treatment of human developmental disorders including infertility, although Shp2 mutations and defects in infertility patients need to be further explored in the clinic.
CONCLUSION
High Shp2 protein levels are necessary for spermatogonia to maintain their self-renewal and survive, but spermatogonia differentiation requires the timely withdrawal of Shp2. In addition, low Shp2 levels play a role in spermatocyte meiosis by regulating RA-induced meiotic gene expression.
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